BRENDA LEAIRD KELLY: Open Payments
NPI 1295760619 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,301 in 108 payments from 21 companies in 2025. Trend: 2023 $1,233 · 2024 $2,554 · 2025 $2,301
Food & beverage: $2,301
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $464 |
| AstraZeneca Pharmaceuticals LP | 13 | $384 |
| Lilly USA, LLC | 11 | $209 |
| GlaxoSmithKline, LLC. | 10 | $180 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $175 |
| Exact Sciences Corporation | 7 | $174 |
| PFIZER INC. | 6 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $99 |
| Amgen Inc. | 5 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $81 |
Products named: XIFAXAN, Cologuard Collection Kit, TRELEGY ELLIPTA, AIRSUPRA, Wegovy, MOUNJARO, JARDIANCE, FARXIGA.
Industry payments across NY — which companies pay providers there.
